Middle-aged women with (overweight/)obesity who will begin or have begun GLP-1 medication use will be recruited to complete a 12-week diet intervention study. For 12-weeks, participants will continue to take their GLP-1 medication and may be provided with protein-rich foods to consume every day. Body composition, eating behavior, health, and well-being will be measured before and after the study.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Body Composition
Timeframe: Baseline and 12 weeks
Muscle Mass
Timeframe: Baseline and 12 weeks
3-day Average Daily Intake
Timeframe: Baseline and 12 weeks